β-Lactamase-IN-1
Product Specifications
UNSPSC Description
β-Lactamase-IN-1 is an inhibitor of β-Lactamase extracted from patent WO2016027249A1, page 77. β-Lactamase-IN-1 can be used to prepare of tricyclic nitrogen containing compound. β-Lactamase-IN-1 can be used for the research of neisseria gonorrhea infection[1].
Target Antigen
Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/beta-lactamase-IN-1.html
Purity
99.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C=NC2=C(N=C(OC)C=C2)N1C(CO)CO
Molecular Weight
251.24
References & Citations
[1]Widdowson KL. Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection. WO2016027249A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19773/β-Lactamase-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19773/β-Lactamase-IN-1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1075237-97-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1189500-01 0.02 mg (E-Coli)
Recombinant Hepatitis B virus genotype G subtype adw2 Capsid protein (C)
Ask
View Details MBS1189500-02 0.1 mg (E-Coli)
Recombinant Hepatitis B virus genotype G subtype adw2 Capsid protein (C)
Ask
View Details